News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Andromeda Says Teva Pharmaceutical Industries Limited (TEVA) to Market Diabetes Treatment



6/22/2009 7:31:26 AM

Bookmark and Share

Reuters -- Israel's Andromeda Biotech said on Monday Teva Pharmaceutical Industries had decided to exercise its option to complete a $13.5 million investment to market Andromeda's treatment for Type I diabetes.


Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES